HIV-1 drug resistance genotyping. A review of clinical and economic issues.

Abstract excerpt

The development of mutations associated with resistance to antiretroviral therapy (ART) has been shown to be a major cause of treatment failure in patients infected with HIV-1. These resistance mutations can be assessed by a genotyping test that probes for specific mutations within the HIV genome or sequences specific genes, at a cost $US500/test (2000 prices). The stated goal of HIV-1 genotyping is to target HIV...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to HIV-1
• Share to HIV Infections
• Share to Anti-HIV Agents